Structural and Functional Perturbation of Giardia lamblia Triosephosphate Isomerase by Modification of a Non-Catalytic, Non-Conserved Region

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Hernández Alcántara, Gloria ^a   Torres Larios, Alfredo ^b   Enríquez Flores, Sergio ^a   García Torres, Itzhel ^a   Castillo Villanueva, Adriana ^a   Méndez, Sara T ^a   de la Mora de la Mora, Ignacio ^a   Gómez Manzo, Saúl ^a   Torres Arroyo, Angélica ^a   López Velázquez, Gabriel ^a   Reyes Vivas, Horacio ^a   Oria Hernández, Jesús ^a  

^a SECRETARÍA DE SALUD   (Mexico)

^b INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; TRIOSEPHOSPHATE ISOMERASE;

AMINO ACID SEQUENCE; ARTICLE; CATALYSIS; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME MODIFICATION; ENZYME STABILITY; ENZYME STRUCTURE; GIARDIA LAMBLIA; LIGAND BINDING; MUTAGENESIS; MUTATION; NONHUMAN; PHYLOGENY; PHYSICAL CHEMISTRY; SEQUENCE ANALYSIS;

BIOCATALYSIS; CONSERVED SEQUENCE; CRYSTALLOGRAPHY, X-RAY; ENZYME STABILITY; GIARDIA LAMBLIA; GLYCOLATES; KINETICS; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SPECTRUM ANALYSIS; TRIOSE-PHOSPHATE ISOMERASE;

EID: 84880679008     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069031     Document Type: Article

References (47)

1. García-Torres I, Gómez-Manzo S, Castillo-Villanueva A, Hernández-Alcántara G, Enríquez-Flores S, et al. (2012) Novel therapeutic approaches for protozoan parasitic diseases. In: Téllez-Valencia A, Pedraza-Reyes M, editors. Current Topics of Drug Design in Parasitic and Bacterial Diseases. Kerala; India: Transworld Research Network. 49-66.
2. Smith E, Morowitz HJ, (2004) Universality in intermediary metabolism. Proc Natl Acad Sci U S A. 101: 13168-13173.
3. Ouzounis C, Kyrpides N, (1996) The emergence of major cellular processes in evolution. FEBS Lett. 390: 119-123.
4. Gómez-Puyou A, Saavedra-Lira E, Becker I, Zubillaga RA, Rojo-Domínguez A, et al. (1995) Using evolutionary changes to achieve species-specific inhibition of enzyme action-studies with triosephosphate isomerase. Chem Biol. 2: 847-855.
5. Maithal K, Ravindra G, Balaram H, Balaram P, (2002) Inhibition of plasmodium falciparum triose-phosphate isomerase by chemical modification of an interface cysteine. Electrospray ionization mass spectrometric analysis of differential cysteine reactivities. J Biol Chem. 277: 25106-25114.
6. Rodríguez-Romero A, Hernández-Santoyo A, del Pozo Yauner L, Kornhauser A, Fernández-Velasco DA, (2002) Structure and inactivation of triosephosphate isomerase from Entamoeba histolytica. J Mol Biol. 322: 669-675.
7. Olivares-Illana V, Pérez-Montfort R, López-Calahorra F, Costas M, Rodríguez-Romero A, et al. (2006) Structural differences in triosephosphate isomerase from different species and discovery of a multitrypanosomatid inhibitor. Biochemistry. 45: 2556-2560.
8. Lalle M, (2010) Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives. Infect Disord Drug Targets. 10: 283-294.
9. Busatti HG, Santos JF, Gomes MA, (2009) The old and new therapeutic approaches to the treatment of giardiasis: where are we?. Biologics. 3: 273-287.
10. Gardner TB, Hill DR, (2001) Treatment of giardiasis. Clin Microbiol Rev. 14: 114-128.
11. Upcroft P, Upcroft JA, (2001) Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev. 14: 150-164.
12. Rossignol JF, (2010) Cryptosporidium and Giardia: treatment options and prospects for new drugs. Exp Parasitol. 124: 45-53.
13. Petri WA, (2005) Treatment of Giardiasis. Curr Treat Options Gastroenterol. 8: 13-17.
14. Dunn LA, Burgess AG, Krauer KG, Eckmann L, Vanelle P, et al. (2010) A new-generation 5-nitroimidazole can induce highly metronidazole-resistant Giardia lamblia in vitro. Int J Antimicrob Agents. 36: 37-42.
15. Adam RD, (2001) Biology of Giardia lamblia. Clin Microbiol Rev. 14: 447-475.
16. Galkin A, Kulakova L, Melamud E, Li L, Wu C, et al. (2007) Characterization, kinetics, and crystal structures of fructose-1,6-bisphosphate aldolase from the human parasite, Giardia lamblia. J Biol Chem. 282: 4859-4867.
17. Hiltpold A, Thomas RM, Köhler P, (1999) Purification and characterization of recombinant pyruvate phosphate dikinase from Giardia. Mol Biochem Parasitol. 104: 157-169.
18. López-Velázquez G, Molina-Ortiz D, Cabrera N, Hernández-Alcántara G, Peon-Peralta J, et al. (2004) An unusual triosephosphate isomerase from the early divergent eukaryote Giardia lamblia. Proteins. 55: 824-834.
19. Reyes-Vivas H, Diaz A, Peon J, Mendoza-Hernandez G, Hernandez-Alcántara G, et al. (2007) Disulfide bridges in the mesophilic triosephosphate isomerase from Giardia lamblia are related to oligomerization and activity. J Mol Biol. 365: 752-763.
20. Enríquez-Flores S, Rodríguez-Romero A, Hernández-Alcántara G, De la Mora-De la Mora I, Gutiérrez-Castrellón P, et al. (2008) Species-specific inhibition of Giardia lamblia triosephosphate isomerase by localized perturbation of the homodimer. Mol Biochem Parasitol. 157: 179-186.
21. Enríquez-Flores S, Rodríguez-Romero A, Hernández-Alcántara G, Oria-Hernández J, Gutiérrez-Castrellón P, et al. (2011) Determining the molecular mechanism of inactivation by chemical modification of triosephosphate isomerase from the human parasite Giardia lamblia: a study for antiparasitic drug design. Proteins. 79: 2711-2724.
22. Oesper P, Meyerhof O, (1950) The determination of triose phosphate isomerase. Arch Biochem. 27: 223-233.
23. González-Mondragón E, Zubillaga RA, Saavedra E, Chánez-Cárdenas ME, Pérez-Montfort R, et al. (2004) Conserved cysteine 126 in triosephosphate isomerase is required not for enzymatic activity but for proper folding and stability. Biochemistry. 43: 3255-3263.
24. Leslie AG, (2006) The integration of macromolecular diffraction data. Acta Crystallogr D Biol Crystallogr. 62: 48-57.
25. Evans P, (2006) Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr. 62: 72-82.
26. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, et al. (2007) Phaser crystallographic software. J Appl Crystallogr. 40: 658-674.
27. Murshudov GN, Skubák P, Lebedev AA, Pannu NS, Steiner RA, et al. (2011) REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr. 67: 355-367.
28. Emsley P, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 60: 2126-2132.
29. Laskowski RA, MacArthur MW, Moss DS, Thornton JM, (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26: 283-291.
30. Eyal E, Gerzon S, Potapov V, Edelman M, Sobolev V, (2005) The limit of accuracy of protein modeling: influence of crystal packing on protein structure. J Mol Biol. 351: 431-442.
31. Pruitt KD, Tatusova T, Klimke W, Maglott DR, (2009) NCBI Reference Sequences: current status, policy and new initiatives. Nucleic Acids Res. 37: D32-D36.
32. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG, (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25: 4876-4882.
33. Benner SA, Cohen MA, Gonnet GH, (1994) Amino acid substitution during functionally constrained divergent evolution of protein sequences. Protein Eng. 7: 1323-1332.
34. Williams JC, McDermott AE, (1995) Dynamics of the flexible loop of triosephosphate isomerase: the loop motion is not ligand gated. Biochemistry. 34: 8309-8319.
35. Rozovsky S, McDermott AE, (2001) The time scale of the catalytic loop motion in triosephosphate isomerase. J Mol Biol. 310: 259-270.
36. Rozovsky S, Jogl G, Tong L, McDermott AE, (2001) Solution-state NMR investigations of triosephosphate isomerase active site loop motion: ligand release in relation to active site loop dynamics. J Mol Biol. 310: 271-280.
37. Aparicio R, Ferreira ST, Polikarpov I, (2003) Closed conformation of the active site loop of rabbit muscle triosephosphate isomerase in the absence of substrate: evidence of conformational heterogeneity. J Mol Biol. 334: 1023-1041.
38. Parthasarathy S, Ravindra G, Balaram H, Balaram P, Murthy MR, (2002) Structure of the Plasmodium falciparum triosephosphate isomerase-phosphoglycolate complex in two crystal forms: characterization of catalytic loop open and closed conformations in the ligand-bound state. Biochemistry. 41: 13178-13188.
39. Pompliano DL, Peyman A, Knowles JR, (1990) Stabilization of a reaction intermediate as a catalytic device: definition of the functional role of the flexible loop in triosephosphate isomerase. Biochemistry. 29: 3186-3194.
40. Kursula I, Salin M, Sun J, Norledge BV, Haapalainen AM, et al. (2004) Understanding protein lids: structural analysis of active hinge mutants in triosephosphate isomerase. Protein Eng Des Sel. 17: 375-382.
41. Wang Y, Berlow RB, Loria JP, (2009) Role of loop-loop interactions in coordinating motions and enzymatic function in triosephosphate isomerase. Biochemistry. 48: 4548-4556.
42. Sampson NS, Knowles JR, (1992) Segmental movement: definition of the structural requirements for loop closure in catalysis by triosephosphate isomerase. Biochemistry. 31: 8482-8487.
43. Kursula I, Wierenga RK, (2003) Crystal structure of triosephosphate isomerase complexed with 2-phosphoglycolate at 0.83-A resolution. J Biol Chem. 278: 9544-9551.
44. Lolis E, Alber T, Davenport RC, Rose D, Hartman FC, et al. (1990) Structure of yeast triosephosphate isomerase at 1.9-A resolution. Biochemistry. 29: 6609-6618.
45. Lolis E, Petsko GA, (1990) Crystallographic analysis of the complex between triosephosphate isomerase and 2-phosphoglycolate at 2.5-A resolution: implications for catalysis. Biochemistry. 29: 6619-25.
46. Noble ME, Zeelen JP, Wierenga RK, (1993) Structures of the "open" and "closed" state of trypanosomal triosephosphate isomerase, as observed in a new crystal form: implications for the reaction mechanism. Proteins. 16: 311-326.
47. Dundas J, Ouyang Z, Tseng J, Binkowski A, Turpaz Y, et al. (2006) CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res. 34: W116-118.